Stock Rating Downgrade Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for Kirby Corp (NYSE: KEX) weakened of late. KEX’s current Value Trend Rating is C and the prior Rating was B. […]
Stock Rating Downgrade The Value Trend Rating for W.R. Berkley Corp (NYSE: WRB) weakened recently from B to C reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in our […]
Stock Rating Downgrade Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for Prudential Financial Inc (NYSE: PRU) weakened recently. PRU’s current Value Trend Rating is C and the prior Rating was B. […]
Stock Rating Downgrade Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for Teekay Corp (NYSE: TK) weakened of late. TK’s current Value Trend Rating is C and the prior Rating was B. […]
Stock Rating Upgrade The Value Trend Rating for Mativ Holdings Inc (NYSE: MATV) improved in recent days from D to C reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included […]
Stock Rating Downgrade Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for Logan Ridge Finance Corp (NASDAQ: LRFC) weakened recently. LRFC’s current Value Trend Rating is C and the prior Rating was […]
Stock Rating Upgrade The Value Trend Rating for Farmers & Merchants Bancorp Inc (NASDAQ: FMAO) improved recently from D to C reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included […]
Stock Rating Upgrade In recent days the Value Trend Rating for Visteon Corp. (NASDAQ: VC) improved from D to C reflecting improving fundamentals and high Appreciation Potential. Recent Price Action On 1/5/24, Visteon Corp. (NASDAQ: […]
Stock Rating Downgrade In the last week the Value Trend Rating for Neurocrine Biosciences Inc (NASDAQ: NBIX) weakened from B to C reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action On 1/5/24, Neurocrine […]
On 1/4/24, Crexendo Inc (NASDAQ: CXDO) stock suffered a major decline of -11.0%, closing at $4.24. Moreover, trading volume in this decline was unusually high at 192% of normal. Relative to the market the stock […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research